Skip to content

Pulse Generator 686, 686B, 686L

by Siemens Elema AB

510(k) K841230

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK841230 Date3 Dec 1984ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Pulse Generator 686, 686B, 686L is an Implantable Pacemaker Pulse-Generator, a Class III medical device designed to regulate cardiac rhythm by delivering electrical impulses to the heart. These devices are intended for patients with bradycardia or other conduction disorders requiring consistent pacing stimulation.

Implanted subcutaneously in the chest, these pulse generators are reusable and require surgical implantation, followed by external programming adjustments. They are regulated under FDA 510(k) clearance (K841230) and fall under the Implantable Pacemaker Pulse-Generator nomenclature (DXY), adhering to regulatory standards for cardiovascular devices. Sterility and MRI safety are critical considerations, as these devices must be handled in sterile conditions and are not MRI-compatible.

Other devices from Siemens Elema AB

See all devices from Siemens Elema AB →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Pulse Generator 686, 686B, and 686L, and how does it function in a patient’s body?

    The Pulse Generator 686, 686B, and 686L are designed to regulate cardiac rhythm by delivering electrical impulses to the heart. They are intended for patients with bradycardia or conduction disorders, providing consistent pacing stimulation to maintain proper heart function. Implanted subcutaneously in the chest, these devices require surgical placement and external programming adjustments to optimize pacing parameters.

  • Are these devices single-use or reusable, and what does that mean for their maintenance and replacement?

    These pulse generators are reusable, meaning they are designed for long-term implantation and can remain in place for extended periods. However, they may require periodic replacement due to battery depletion or other factors, and maintenance involves external programming adjustments rather than device replacement for routine use.

  • What special considerations should be taken into account when handling or storing these devices?

    Sterility is critical when handling these devices, as they are implanted surgically. Additionally, they are not MRI-compatible, so patients must avoid MRI scans to prevent potential damage or interference. Storage should follow manufacturer guidelines to preserve functionality and sterility.

  • How were these devices approved by the FDA, and what does that mean for their use in clinical settings?

    The Pulse Generator 686, 686B, and 686L received FDA clearance through a 510(k) submission (K841230), which means they were determined to be substantially equivalent to a legally marketed device already on the market. This approval route ensures they meet regulatory standards for cardiovascular devices, allowing their use in clinical settings for patients requiring pacemaker therapy.